- Home
- BB vs SRRK Comparison
BB vs SRRK Comparison
Compare BB & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- SRRK
- Stock Information
- Founded
- BB 1984
- SRRK 2012
- Country
- BB Canada
- SRRK United States
- Employees
- BB N/A
- SRRK N/A
- Industry
- BB
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BB
- SRRK Health Care
- Exchange
- BB Nasdaq
- SRRK Nasdaq
- Market Cap
- BB 2.8B
- SRRK 3.0B
- IPO Year
- BB 1997
- SRRK 2018
- Fundamental
- Price
- BB $4.16
- SRRK $37.85
- Analyst Decision
- BB Hold
- SRRK Strong Buy
- Analyst Count
- BB 6
- SRRK 11
- Target Price
- BB $4.98
- SRRK $47.30
- AVG Volume (30 Days)
- BB 8.7M
- SRRK 2.1M
- Earning Date
- BB 12-18-2025
- SRRK 11-14-2025
- Dividend Yield
- BB N/A
- SRRK N/A
- EPS Growth
- BB N/A
- SRRK N/A
- EPS
- BB N/A
- SRRK N/A
- Revenue
- BB $536,600,000.00
- SRRK N/A
- Revenue This Year
- BB $2.43
- SRRK N/A
- Revenue Next Year
- BB $7.36
- SRRK $1,987.65
- P/E Ratio
- BB N/A
- SRRK N/A
- Revenue Growth
- BB N/A
- SRRK N/A
- 52 Week Low
- BB $2.29
- SRRK $22.71
- 52 Week High
- BB $6.24
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- BB 35.76
- SRRK 63.65
- Support Level
- BB $4.10
- SRRK $29.35
- Resistance Level
- BB $4.35
- SRRK $39.50
- Average True Range (ATR)
- BB 0.17
- SRRK 2.05
- MACD
- BB -0.06
- SRRK 1.28
- Stochastic Oscillator
- BB 5.42
- SRRK 78.82
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.